Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24
Rhea-AI Summary
Stonegate Capital Partners has updated its coverage on Bio-Path Holdings (NASDAQ: BPTH) for the third quarter of 2024. The detailed announcement includes downloadable images, bios, and more information. For the complete announcement, click the image above.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, BPTH gained 1.32%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Dallas, Texas--(Newsfile Corp. - December 13, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q3 2024.
To view the full announcement, including downloadable images, bios, and more, click here.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233787
FAQ
What is the latest coverage update on BPTH?
Who updated the coverage on Bio-Path Holdings for Q3 2024?
Where can I find the full announcement of BPTH's Q3 2024 coverage update?
What stock symbol does Bio-Path Holdings trade under?
